MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited Current Ratio 2011-2026 | BNR
Annual Current Ratio Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.26 | 11 | 4 | 0.382 | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 | 0.382 | 5.16 |
Quarterly Current Ratio Burning Rock Biotech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.26 | - | - | - | 11 | - | - | - | 4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11 | 4 | 6.75 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.13 | - | $ 6.15 M |  USA |
 |
Agilent Technologies
A
|
2.01 | $ 115.27 | 0.17 % | $ 35 B | USA |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 16.35 | 1.87 % | $ 871 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
6.01 | $ 1.38 | 0.91 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 23.14 | 0.04 % | $ 643 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 176.98 | 0.74 % | $ 8.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 496.91 | 0.68 % | $ 14.3 B | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 191.04 | 0.78 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.45 | 2.18 % | $ 412 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 122.89 | 1.62 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 7.9 | 2.67 % | $ 1.01 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 14.96 | 3.64 % | $ 452 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 79.03 | 0.54 % | $ 9.91 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
7.55 | $ 2.76 | 2.6 % | $ 89.6 K | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.07 | -3.27 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 28.14 | -0.58 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 107.18 | 0.35 % | $ 8.84 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 260.85 | -0.03 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
2.02 | $ 197.77 | 2.46 % | $ 19.5 B | USA |
 |
Celcuity
CELC
|
1.27 | $ 118.02 | 0.75 % | $ 5.52 B | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.61 | -1.05 % | $ 276 M | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 80.46 | -0.17 % | $ 5.43 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 190.61 | -0.48 % | $ 21.2 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 52.6 | -0.06 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
2.51 | $ 9.09 | -3.56 % | $ 1.97 B | USA |
 |
ENDRA Life Sciences
NDRA
|
2.42 | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |